Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigil Haroon

Showing results (121-130 of 149) with videos related to

Pageof 15
Sort By:
The Journal of Rheumatology|December 1, 2022
Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial SpondyloarthritisRobert D Inman, Marco Garrido-Cumbrera, Jonathan Chan, et al.
Annals of the Rheumatic Diseases|October 6, 2018
microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee jointsAkihiro Nakamura, Yoga Raja Rampersaud, Sayaka Nakamura, et al.
Cellular & Molecular Immunology|June 5, 2024
HIF-1α and MIF enhance neutrophil-driven type 3 immunity and chondrogenesis in a murine spondyloarthritis modelAkihiro Nakamura, Sungsin Jo, Sayaka Nakamura, et al.
Annals of the Rheumatic Diseases|July 8, 2024
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trialsMatthew A Brown, Martin Rudwaleit, Floris A van Gaalen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 6, 2018
Proinflammatory CX3CR1+CD59+Tumor Necrosis Factor-Like Molecule 1A+Interleukin-23+ Monocytes Are Expanded in Patients With Ankylosing Spondylitis and Modulate Innate Lymphoid Cell 3 Immune FunctionsFrancesco Ciccia, Giuliana Guggino, Michael Zeng, et al.
The Journal of Rheumatology|February 17, 2015
2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management RecommendationsSherry Rohekar, Jon Chan, Shirley M L Tse, et al.
The Journal of Rheumatology|February 17, 2015
2014 Update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in CanadaSherry Rohekar, Jon Chan, Shirley M L Tse, et al.
Musculoskeletal Care|December 10, 2024
Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS)Proton Rahman, Marco Garrido-Cumbrera, Sherry Rohekar, et al.
Clinical Immunology (Orlando, Fla.)|April 19, 2023
Prostaglandin E2/EP4 axis is upregulated in Spondyloarthritis and contributes to radiographic progressionDaniele Mauro, Archita Srinath, Giuliana Guggino, et al.
The Journal of Rheumatology|July 1, 2024
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial SpondyloarthritisSherry Rohekar, Jordi Pardo Pardo, Reza Mirza, et al.
Pageof 15

Showing results (121-130 of 149) with videos related to

Sort By:
Pageof 15
The Journal of Rheumatology|December 1, 2022
Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial SpondyloarthritisRobert D Inman, Marco Garrido-Cumbrera, Jonathan Chan, et al.
Annals of the Rheumatic Diseases|October 6, 2018
microRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee jointsAkihiro Nakamura, Yoga Raja Rampersaud, Sayaka Nakamura, et al.
Cellular & Molecular Immunology|June 5, 2024
HIF-1α and MIF enhance neutrophil-driven type 3 immunity and chondrogenesis in a murine spondyloarthritis modelAkihiro Nakamura, Sungsin Jo, Sayaka Nakamura, et al.
Annals of the Rheumatic Diseases|July 8, 2024
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trialsMatthew A Brown, Martin Rudwaleit, Floris A van Gaalen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 6, 2018
Proinflammatory CX3CR1+CD59+Tumor Necrosis Factor-Like Molecule 1A+Interleukin-23+ Monocytes Are Expanded in Patients With Ankylosing Spondylitis and Modulate Innate Lymphoid Cell 3 Immune FunctionsFrancesco Ciccia, Giuliana Guggino, Michael Zeng, et al.
The Journal of Rheumatology|February 17, 2015
2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management RecommendationsSherry Rohekar, Jon Chan, Shirley M L Tse, et al.
The Journal of Rheumatology|February 17, 2015
2014 Update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in CanadaSherry Rohekar, Jon Chan, Shirley M L Tse, et al.
Musculoskeletal Care|December 10, 2024
Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS)Proton Rahman, Marco Garrido-Cumbrera, Sherry Rohekar, et al.
Clinical Immunology (Orlando, Fla.)|April 19, 2023
Prostaglandin E2/EP4 axis is upregulated in Spondyloarthritis and contributes to radiographic progressionDaniele Mauro, Archita Srinath, Giuliana Guggino, et al.
The Journal of Rheumatology|July 1, 2024
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial SpondyloarthritisSherry Rohekar, Jordi Pardo Pardo, Reza Mirza, et al.
Pageof 15